Latest Breaking News On - Mario rovirosa - Page 1 : comparemela.com

Ferrer to develop, market PIKfyve inhibitor VRG50635

Ferrer to develop, market PIKfyve inhibitor VRG50635
alsnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alsnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesAlice zhangMario rovirosaVerge genomicSouth americaSoutheast asia

Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635

VRG50635 is one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled platformSOUTH SAN FRANCISCO, Calif. and BARCELONA, Spain, March 25, 2024 (GLOBE NEWSWIRE) Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer, an international B Corp pharmaceutical company with an increasing focus in rare neurological disorders, have announced a strategic collaboration to co-develop VRG50635, Verge’s lead drug candidate, for the tr

United statesComunidad autonoma de catalunaVan dammeCarlo ferriAlice zhangMario rovirosaAdam silversteinBusiness developmentB corpSouth americaSoutheast asiaVerge genomicsChief scientificBusiness development officerAmyotrophic lateral sclerosisLateral sclerosis

Ferrer Allocates, On Average, More Than 40% Of Its Profits To Social And Environmental Projects For The Third Consecutiv

Ferrer Allocates, On Average, More Than 40% Of Its Profits To Social And Environmental Projects For The Third Consecutiv
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Mario rovirosaB corpCarbon disclosure project supplier engagementEcovadis gold

Ferrer Allocates, on Average, More Than 40% of its Profits to Social and Environmental Projects for the Third Consecutive Year

Ferrer Allocates, on Average, More Than 40% of its Profits to Social and Environmental Projects for the Third Consecutive Year
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Mario rovirosaB corpSustainability reportCarbon disclosure project supplierAktien sie

Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)

ASN90, an O-GlcNAcase inhibitor, is a new chemical entity at clinical stage and a promising candidate for the treatment of PSP, a disorder with a high unmet medical need PSP is a rare neurological

Dennis riedlMario rovirosaCatherine moukheibirOfficerand coAb corpBusiness developmentChief marketingPricing market accessBusiness development officerDirk beherRare disease dayChief executive officerChief executive officerand co founderChief business developmentGlobal alliances officer